Inventor · disambiguated record
Ib Jarle Christensen
Also filed as: CHRISTENSEN IB JARLE
4 granted patents·5 pending applications·4 citations·filing 2002–2011
62Inventor score
Technology areasG01N
Top patents by PatentIndex Score
9 records- 0172US7807379B2Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer markerRIGSHOSPITALET·Filed 2006·Granted Oct 5, 2010·3 cites·29 claims
- 0254US2008261246A1Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancerRIGSHOSPITALET·Filed 2008·Application pending·0 cites
- 0350US2011294148A1Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancerHOLTEN-ANDERSEN MADS NIKOLAJ·Filed 2011·Application pending·0 cites
- 0450US2011060529A1Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer markerRIGSHOSPITALET·Filed 2010·Application pending·0 cites
- 0549US7374886B2Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancerRIGSHOSPITALET·Filed 2002·Granted May 20, 2008·1 cites·31 claims
- 0636US8697384B2YKL-40 as a general marker for non-specific diseaseJOHANSEN JULIA·Filed 2009·Granted Apr 15, 2014·0 cites·21 claims
- 0735US8580520B2YKL-40 as a marker for gastrointestinal cancersJOHANSEN JULIA SIDENIUS·Filed 2009·Granted Nov 12, 2013·0 cites·14 claims
- 0835US2012040354A1Methods of classifying the severity of diseases or disordersJOHANSEN JULIA SIDENIUS·Filed 2009·Application pending·0 cites
- 0935US2012040355A1Ykl-40 as a marker for selection of treatment and monitoring of a diseaseJOHANSEN JULIA SIDENIUS·Filed 2009·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ib Jarle Christensen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →